Unleash Immuno Oncolytics
Unleash Immuno Oncolytics's email is info@unleash.bio
and
Unleash Immuno Oncolytics's phone number is 314-730-0050
.
Unleash IO develops oncolytic immunotherapy products shown to be highly specific and efficacious in animal models and human tissue samples. Unleash IO’s leading product, UIO-512, is an oncolytic adenovirus that targets both malignant cells and tumor-associated stroma cells. UIO-512 is armed with GM-CSF, a potent immune-modulatory cytokine, triggering an immune response towards the tumor. UIO-512 lead indication is in ovarian cancer, follow on indications include other solid tumors such as glioblastoma, melanoma and pancreatic cancer. Promising pre-clinical results in ani...
read more
Unleash IO develops oncolytic immunotherapy products shown to be highly specific and efficacious in animal models and human tissue samples. Unleash IO’s leading product, UIO-512, is an oncolytic adenovirus that targets both malignant cells and tumor-associated stroma cells. UIO-512 is armed with GM-CSF, a potent immune-modulatory cytokine, triggering an immune response towards the tumor. UIO-512 lead indication is in ovarian cancer, follow on indications include other solid tumors such as glioblastoma, melanoma and pancreatic cancer. Promising pre-clinical results in animal models and fresh human samples of ovarian cancers as well as in melanoma were published in top ranked peer-reviewed publications. Unleash IO is raising $3.5 M to conduct a phase I/II clinical trial in ovarian cancer with oncolytic immunotherapy UIO-512.
show less
Website | unleash.bio | |
Industry | Biotechnology | |
Location | Saint Louis, Missouri, United States | |
Employees | 4 |
HQ | 4240 Duncan Ave, Suite 200 | |
Phone | 314-730-0050 | |
info@unleash.bio | ||
Funding | 3,000,000 USD | |
Competitors | Roche, Agilent Technologies, Amgen, Genentech, Eurofins, Gilead Sciences, |
Website | unleash.bio | |
Industry | Biotechnology | |
Location | Saint Louis, Missouri, United States | |
Employees | 4 | |
linkedin.com/company/unleash-immuno-oncolytics | ||
HQ | 4240 Duncan Ave, Suite 200 | |
Phone | 314-730-0050 | |
info@unleash.bio | ||
Funding | 3,000,000 USD |
Top Competitors for Unleash Immuno Oncolytics
Unleash Immuno Oncolytics Questions
Where are Unleash Immuno Oncolytics's headquarters?
Unleash Immuno Oncolytics's headquarters are in 4240 Duncan Ave, Suite 200
What is Unleash Immuno Oncolytics's phone number?
Unleash Immuno Oncolytics's phone number is 314-730-0050
What is Unleash Immuno Oncolytics's official website?
Unleash Immuno Oncolytics's website is unleash.bio
How many employees are working in Unleash Immuno Oncolytics right now?
Unleash Immuno Oncolytics has
4 employees.
View the Email and Phone Numbers for all 4 working at Unleash Immuno Oncolytics.
What is Unleash Immuno Oncolytics's industry?
Unleash Immuno Oncolytics's industry is
Biotechnology
Who are Unleash Immuno Oncolytics's top competitors?
Unleash Immuno Oncolytics's top competitors are
Roche
,
Agilent Technologies
,
Amgen
,
Genentech
,
Eurofins
,
Gilead Sciences
What is Unleash Immuno Oncolytics's email address?
Unleash Immuno Oncolytics's email address is info@unleash.bio
What are Unleash Immuno Oncolytics's categories?
Unleash Immuno Oncolytics's categories are Biotechnology, Medical Device, Therapeutics
What is Unleash Immuno Oncolytics's location?
Unleash Immuno Oncolytics's location is
Saint Louis, Missouri, United States
What is Unleash Immuno Oncolytics's funding?
Unleash Immuno Oncolytics's funding is 3,000,000 USD
What is Unleash Immuno Oncolytics's current status?
Unleash Immuno Oncolytics's current status is operating